Maravai LifeSciences Holdings, Inc. MRVI Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$184.29M+36.4% | -$230.76M+11.1% | -$213.81M+33.9% | -$341.21M-105% | -$289.8M-81.5% | ||
| $22.77M+4.6% | $23.56M+13.0% | $23.09M+19.5% | $22.16M+20.8% | $21.76M+39.4% | ||
| $26.51M-44.5% | $30.17M-38.9% | $36.79M-23.7% | $40.79M-9.7% | $47.76M+17.5% | ||
| $72.77M-59.3% | $84.6M-49.1% | $54.85M-64.4% | $209.08M— | $178.64M— | ||
| —— | —— | —— | —— | —— | ||
| -$7.58M-126,283% | -$8M-2,022% | -$5.36M— | -$2.41M— | -$6K— | ||
| -$477K-113% | -$7.35M-1,116% | $422K+230% | $908K-80.0% | $3.7M+101% | ||
| -$11.8M— | -$4.63M— | $7.32M— | $4.75M— | —— | ||
| -$818K— | -$1.63M— | -$1.29M— | -$661K— | —— | ||
| -$10.34M+24.3% | -$18.63M-196% | -$17.89M-163% | -$16.13M-113% | -$13.66M-110% | ||
| —— | —— | —— | —— | —— | ||
| $27.39M-1.1% | $27.95M+1.5% | $28.34M+3.1% | $28.02M+2.0% | $27.69M+0.8% | ||
| $8.38M-2.2% | $8.96M+5.7% | $8.83M+3.9% | $8.68M+1.4% | $8.57M+0.1% | ||
| -$39.52M— | -$57.57M— | —— | —— | —— | ||
| $13.09M-54.1% | $13.15M-55.7% | $16.88M-58.4% | $22.55M-52.9% | $28.49M-55.0% | ||
| —— | —— | —— | $18.99M— | $18.63M— | ||
| —— | $0-100% | $450K-66.7% | $900K0.0% | $1.35M+200% | ||
| -$12.71M+70.6% | -$31.41M-29.2% | -$34.22M-6.0% | -$40.26M-3.6% | -$43.2M+24.0% | ||
| $55.44M-76.3% | $5.44M-97.7% | $234.39M+4,209% | $234.39M+4,209% | $234.39M+4,209% | ||
| —— | —— | —— | —— | —— | ||
| -$66.83M+72.2% | -$16.5M+93.0% | -$250.87M— | -$241.81M— | -$240.28M— | ||
| —— | —— | -$46K— | -$38K— | $73K— | ||
| -$119.13M+58.7% | -$105.51M+60.0% | -$334.58M-2,488% | -$303.26M-1,541% | -$288.12M-333% | ||
| $24.6M-45.7% | $24.98M-51.0% | $33.88M-29.3% | $39.6M-16.9% | $45.35M-3.1% | ||
| -$700K-214% | -$561K-184% | -$535K— | -$242K— | $612K— | ||
| $27.39M-1.1% | $27.95M+1.5% | $28.34M+3.1% | $28.02M+2.0% | $27.69M+0.8% | ||
| —— | —— | —— | —— | $137.05M+230% | ||
| $22.77M+4.6% | $23.56M+13.0% | $23.09M+19.5% | $22.16M+20.8% | $21.76M+39.4% | ||
| -$10.34M+24.3% | -$18.63M-196% | -$17.89M-163% | -$16.13M-113% | -$13.66M-110% | ||
| —— | -$181K-18.3% | -$174K+47.3% | -$167K+67.1% | -$160K+76.6% | ||
| -$818K— | -$1.63M— | -$1.29M— | -$661K— | —— | ||
| $8.38M-2.2% | $8.96M+5.7% | $8.83M+3.9% | $8.68M+1.4% | $8.57M+0.1% | ||
| —— | —— | —— | —— | —— | ||
| —— | $0-100% | $450K-66.7% | $900K0.0% | $1.35M+200% | ||
| —— | -$10K-102% | $116K-95.8% | $242K-95.2% | $368K-95.0% | ||
| —— | $0-100% | $1.78M-88.8% | $3.55M-85.6% | $5.33M-84.0% | ||
| —— | —— | —— | —— | -$4.86M-590% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $4.8M— | ||
| —— | —— | —— | —— | —— | ||
| -$700K-214% | -$561K-184% | -$535K— | -$242K— | $612K— | ||
| -$52.6M— | -$70.72M— | -$66.33M— | —— | —— | ||
| -$52.6M— | -$70.72M— | -$66.33M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Maravai LifeSciences Holdings, Inc. generate?
- Maravai LifeSciences Holdings, Inc. (MRVI) generated -$39.5M in operating cash flow over the trailing twelve months.
- What is Maravai LifeSciences Holdings, Inc.'s free cash flow?
- After $13.1M of capital expenditures, Maravai LifeSciences Holdings, Inc.'s free cash flow was -$52.6M over the trailing twelve months, down 283.3% year over year.
- Where does Maravai LifeSciences Holdings, Inc.'s cash flow data come from?
- Every line is extracted from Maravai LifeSciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
